CD8A and neoplasm: As mentioned above, tumors have developed mechanisms to suppress T cells in the tumor microenvironment (TME) and that the field of cancer immunotherapy focuses on re-establishing cytotoxic CD8+ T cell-mediated killing of cancer cells by, for example, the use of checkpoint inhibitors.